Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer: A meta-analysis

BACKGROUND: The aim of this meta-analysis is to investigate the impact of Osimertinib on treatment efficacy in advanced nonsmall cell lung cancer (NSCLC). METHODS: Trials comparing Osimertinib against epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)/chemotherapy in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lei, Huang, Hao, Zhou, Xiao-Ping, Liu, Jin-Feng, Li, Chun-Rong, Fang, Min, Wu, Jun-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824777/
https://www.ncbi.nlm.nih.gov/pubmed/31651902
http://dx.doi.org/10.1097/MD.0000000000017705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824777/
https://www.ncbi.nlm.nih.gov/pubmed/31651902
http://dx.doi.org/10.1097/MD.0000000000017705

Ejemplares similares